Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.69% | $25.59M | €341.65B | 37.83% | 78 Outperform | |
| AstraZeneca | 2.39% | $22.71M | $259.50B | 10.59% | 77 Outperform | |
| Rolls-Royce Holdings | 2.02% | $19.15M | £94.31B | 104.11% | 71 Outperform | |
| UniCredit SpA | 1.74% | $16.50M | €95.53B | 72.51% | 75 Outperform | |
| Unilever | 1.42% | $13.49M | £114.97B | -2.93% | 77 Outperform | |
| Siemens | 1.38% | $13.09M | €190.79B | 36.95% | 74 Outperform | |
| Sony | 1.30% | $12.38M | ¥26.74T | 68.43% | 74 Outperform | |
| Prosus | 1.30% | $12.32M | €130.11B | 66.87% | 77 Outperform | |
| SAP SE | 1.29% | $12.25M | €272.35B | 5.72% | 73 Outperform | |
| Roche Holding AG | 1.24% | $11.82M | CHF217.35B | 4.21% | 73 Outperform |